TapImmune To Present At Biotech Showcase 2017

Jacksonville FL, January 5, 2017TapImmune, Inc. (NASDAQ: TPIV), a clinical stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer and metastatic disease, today announced its Chairman and CEO, Dr. Glynn Wilson, will present at Biotech Showcase 2017 to be held January 9-11, 2017, at the Hilton San Francisco Union Square.

Details of the presentation are as follows:



Biotech Showcase 2017



Tuesday, January 10, 2017



9:00 a.m. (Pacific Time)



Hilton San Francisco Union Square

The webcast of the presentation can be viewed live and will be available for three months after the event by clicking on the following link: https://event.webcasts.com/starthere.jsp?ei=1130636